Literature DB >> 19898244

Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia.

Gianluca Trifirò1, Giovanna Sini, Miriam C J M Sturkenboom, Nicola Vanacore, Giampiero Mazzaglia, Achille P Caputi, Claudio Cricelli, Ovidio Brignoli, Eugenio Aguglia, Giovanni Biggio, Fabio Samani.   

Abstract

The objective of this study was to evaluate the antipsychotic drug prescribing pattern in the Italian general population, elderly, and especially elderly with dementia, in relation to the safety warnings issued by international regulatory agencies about the risk of cerebrovascular adverse events and mortality in 2004 and 2005. A cohort study was conducted using the electronic medical records of the Italian general practice database 'Health Search/Thales'. On the basis of prescription data, 1-year and monthly prevalence estimates were calculated for atypical and typical antipsychotic use in general population, elderly, and elderly demented outpatients. One-year prevalence of individual medication use in elderly demented patients was calculated as well. The prevalence of use of atypical agents in demented patients progressively increased from 2000 [0.2 (0.05-0.7) per 10 000] until the beginning of 2004 [9.7 (8.1-11.6) per 10 000], after which a slight decrease started, whereas the prevalence of use of typical antipsychotics decreased from 2001 [15.7 (13.5-18.2) per 10 000] until 2004 [10.7 (9.0-12.7) per 10 000], then slightly increased in December 2005 [12.1 (10.4-14.2) per 10 000]. Monthly trends in general population and elderly were quite similar and differed significantly from the trend in elderly with dementia: stable use of atypicals from 2002 to 2005 and strong reduction of typicals from 2001 to the end of 2004. The recent safety warnings led to an increasing trend in the use of typical agents and decreasing trend in the use of atypical agents in elderly demented outpatients in Italy. Similar trends were not observed in general population and elderly as a whole.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19898244     DOI: 10.1097/YIC.0b013e3283334f08

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  8 in total

Review 1.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

2.  Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study.

Authors:  J Sultana; I Leal; M de Ridder; M Sturkenboom; G Trifiró
Journal:  Epidemiol Psychiatr Sci       Date:  2016-03-18       Impact factor: 6.892

3.  Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Authors:  Alessandro Oteri; Giampiero Mazzaglia; Serena Pecchioli; Mariam Molokhia; Sinna Pilgaard Ulrichsen; Lars Pedersen; Elisabetta Poluzzi; Fabrizio De Ponti; Edeltraut Garbe; Tania Schink; Ron Herings; Irene D Bezemer; Miriam C J M Sturkenboom; Gianluca Trifirò
Journal:  Br J Clin Pharmacol       Date:  2016-05-18       Impact factor: 4.335

4.  The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.

Authors:  Janet Sultana; Andrea Fontana; Francesco Giorgianni; Alessandro Pasqua; Claudio Cricelli; Edoardo Spina; Giovanni Gambassi; Jelena Ivanovic; Carmen Ferrajolo; Mariam Molokhia; Clive Ballard; Samantha Sharp; Miriam Sturkenboom; Gianluca Trifirò
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

5.  How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia.

Authors:  Francesca Galeotti; Nicola Vanacore; Sabina Gainotti; Fabio Izzicupo; Francesca Menniti-Ippolito; Carlo Petrini; Flavia Chiarotti; Rabih Chattat; Roberto Raschetti
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

6.  Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Manuela Tabali; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Geriatr       Date:  2010-07-21       Impact factor: 3.921

7.  Antipsychotic drug use and community-acquired pneumonia.

Authors:  Gianluca Trifirò
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

8.  Antipsychotic Drug Dispensations in Older Adults, Including Continuation After a Fall-Related Hospitalization: Identifying Adherence to Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria Using the Nova Scotia Seniors' Pharmacare Program and Canadian Institute for Health's Discharge Databases.

Authors:  Shanna C Trenaman; Barbara J Hill-Taylor; Kara J Matheson; David M Gardner; Ingrid S Sketris
Journal:  Curr Ther Res Clin Exp       Date:  2018-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.